Industry Sponsored Symposium - Managing Gastroesophageal Reflux Disease: Who is in the Waiting Room?

Philip O. Katz, MD, MACG; C. Prakash Gyawali, MD, MRCP, FACG; Rena H. Yadlapati, MD, MSHS, FACG

Supported by an independent educational grant from Phathom Pharmaceuticals.

Gastroesophageal reflux disease (GERD) is one of the most common reasons for visits to gastrointestinal (GI) specialists in the United States. Up to half of patients with reflux symptoms do not get adequate relief from empiric therapy with proton pump inhibitors and require more advanced management. In this live, interactive symposium, expert faculty will discuss the latest clinical evidence regarding the diagnosis and management of GERD, erosive esophagitis (EE), and nonerosive reflux disease (NERD), including the evidence for newly approved acid suppressive medications. Faculty will present real-world patient cases to help learners contextualize important clinical information on GERD evaluation and management that they can apply in their own practices.


Industry-Sponsored Satellite Symposia provide additional educational opportunities for attendees. These programs are independent of the ACG 2024 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at link www.medscape.org/symposium/gerd-cases